News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
738,008 Results
Type
Article (50594)
Company Profile (285)
Press Release (687129)
Multimedia
Podcasts (66)
Webinars (12)
Section
Business (212624)
Career Advice (2113)
Deals (36590)
Drug Delivery (104)
Drug Development (83777)
Employer Resources (173)
FDA (17013)
Job Trends (15749)
News (359844)
Policy (34740)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2797)
Accelerated approval (5)
Adcomms (23)
Allergies (87)
Alliances (51697)
ALS (93)
Alzheimer's disease (1452)
Antibody-drug conjugate (ADC) (129)
Approvals (17016)
Artificial intelligence (273)
Autoimmune disease (22)
Automation (16)
Bankruptcy (374)
Best Places to Work (12112)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (198)
Bladder cancer (79)
Brain cancer (28)
Breast cancer (290)
Cancer (2304)
Cardiovascular disease (185)
Career advice (1770)
Career pathing (31)
CAR-T (153)
Cell therapy (427)
Cervical cancer (21)
Clinical research (67988)
Collaboration (861)
Compensation (527)
Complete response letters (21)
COVID-19 (2720)
CRISPR (40)
C-suite (251)
Cystic fibrosis (101)
Data (2217)
Decentralized trials (2)
Denatured (28)
Depression (53)
Diabetes (275)
Diagnostics (6579)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (122)
Drug pricing (106)
Drug shortages (28)
Duchenne muscular dystrophy (95)
Earnings (88764)
Editorial (40)
Employer branding (21)
Employer resources (147)
Events (117564)
Executive appointments (735)
FDA (18300)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (770)
Gene editing (107)
Generative AI (25)
Gene therapy (307)
GLP-1 (761)
Government (4692)
Grass and pollen (4)
Guidances (55)
Healthcare (19932)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (119)
Indications (30)
Infectious disease (2868)
Inflammatory bowel disease (141)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (97)
Interviews (323)
IPO (16895)
IRA (41)
Job creations (4060)
Job search strategy (1511)
Kidney cancer (10)
Labor market (38)
Layoffs (484)
Leadership (17)
Legal (8483)
Liver cancer (78)
Lung cancer (329)
Lymphoma (153)
Machine learning (7)
Management (58)
Manufacturing (310)
MASH (69)
Medical device (14389)
Medtech (14394)
Mergers & acquisitions (20244)
Metabolic disorders (716)
Multiple sclerosis (81)
NASH (16)
Neurodegenerative disease (103)
Neuropsychiatric disorders (32)
Neuroscience (2020)
NextGen: Class of 2025 (6929)
Non-profit (4749)
Northern California (2680)
Now hiring (39)
Obesity (384)
Opinion (219)
Ovarian cancer (76)
Pain (88)
Pancreatic cancer (84)
Parkinson's disease (156)
Partnered (21)
Patents (235)
Patient recruitment (110)
Peanut (48)
People (60250)
Pharmaceutical (68)
Pharmacy benefit managers (20)
Phase I (21152)
Phase II (29870)
Phase III (22322)
Pipeline (1189)
Policy (141)
Postmarket research (2743)
Preclinical (9052)
Press Release (67)
Prostate cancer (109)
Psychedelics (32)
Radiopharmaceuticals (256)
Rare diseases (390)
Real estate (6322)
Recruiting (65)
Regulatory (23720)
Reports (46)
Research institute (2491)
Resumes & cover letters (360)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (76)
Series A (132)
Series B (87)
Service/supplier (13)
Sickle cell disease (53)
Southern California (2307)
Special edition (16)
Spinal muscular atrophy (152)
Sponsored (31)
Startups (3841)
State (2)
Stomach cancer (14)
Supply chain (71)
Tariffs (37)
The Weekly (36)
United States (23463)
Vaccines (726)
Venture capitalists (42)
Weight loss (260)
Women's health (38)
Worklife (15)
Date
Today (218)
Last 7 days (885)
Last 30 days (2752)
Last 365 days (33710)
2025 (10729)
2024 (36168)
2023 (41207)
2022 (52437)
2021 (57163)
2020 (55951)
2019 (48868)
2018 (36995)
2017 (33814)
2016 (33684)
2015 (39728)
2014 (33459)
2013 (28751)
2012 (30987)
2011 (31634)
2010 (29997)
Location
Africa (794)
Alabama (54)
Alaska (7)
Arizona (239)
Arkansas (14)
Asia (41117)
Australia (6787)
California (6138)
Canada (2019)
China (538)
Colorado (277)
Connecticut (288)
Delaware (150)
Europe (89361)
Florida (910)
Georgia (213)
Idaho (61)
Illinois (570)
India (26)
Indiana (314)
Iowa (11)
Japan (162)
Kansas (107)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (926)
Massachusetts (4637)
Michigan (223)
Minnesota (403)
Mississippi (2)
Missouri (83)
Montana (27)
Nebraska (25)
Nevada (65)
New Hampshire (68)
New Jersey (1744)
New Mexico (30)
New York (1753)
North Carolina (1031)
North Dakota (8)
Northern California (2680)
Ohio (204)
Oklahoma (14)
Oregon (35)
Pennsylvania (1379)
Puerto Rico (12)
Rhode Island (35)
South America (1186)
South Carolina (23)
South Dakota (1)
Southern California (2307)
Tennessee (103)
Texas (914)
Utah (184)
Virginia (148)
Washington D.C. (65)
Washington State (572)
West Virginia (3)
Wisconsin (55)
738,008 Results for "neuros medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI
April 29, 2025
·
4 min read
Business
Neuros Medical Strengthens Senior Leadership Team in Preparation for Commercialization of the Altius® System
Neuros Medical, Inc. today announced the appointment of Zach Stassen , Chief Financial Officer (CFO); Kirk Ellis, Vice President of U.S. Sales; and Steve Bosrock, Vice President of Marketing.
June 5, 2024
·
4 min read
Press Releases
Terumo Neuro Receives FDA Approval for Carotid Stent System
April 15, 2025
·
2 min read
Pipeline
AstraZeneca Abandons Neuroscience, Prioritizes Weight Loss, Immunology
Following the recent discontinuations of assets in Alzheimer’s and migraine, AstraZeneca is stepping away from neuro altogether.
April 29, 2025
·
3 min read
·
Tristan Manalac
Biotech Beach
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial
ClearPoint Neuro, Inc. congratulates its partner Aspen Neuroscience, Inc. on use of the ClearPoint Neuro Navigation System to transplant dopaminergic neuron precursor cells for all enrolled patients with Parkinson’s Disease in its recently launched ASPIRO Phase 1/2a clinical trial.
June 20, 2024
·
6 min read
Press Releases
Sense Neuro Diagnostics appoints Gary Kurdziel as Chief Executive Officer
March 24, 2025
·
3 min read
Press Releases
ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025
April 25, 2025
·
4 min read
Neuroscience
2024 Highlights the Rollercoaster That Is Neuro
This year saw lofty highs and devastating lows for neuroscience drug developers like Bristol Myers Squibb, Eli Lilly and AbbVie, following the predictable pattern of successes and failures that characterizes this space.
December 23, 2024
·
6 min read
·
Heather McKenzie
Business
Neuros Medical, Inc. Names David Veino as President and CEO and Expands Board of Directors
Neuros Medical, Inc. today announced that David Veino has been appointed President and Chief Executive Officer.
October 23, 2023
·
4 min read
Neuroscience
GSK Dives Deeper Into Neuro With $2.5B+ ABL Bio Pact
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
April 7, 2025
·
2 min read
·
Tristan Manalac
1 of 73,801
Next
